Natural product-based Lifespan extension therapy: Cilostazol may prolong mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 8/April/2014, 12.07 pm

Natural product-based therapy for p53-deficient tumors: Epigallogalectin, the main component of Green tea, suppresses and increases the expression of DNp63α and IAPP(Amylin), respectively, and induces regression of p53-mutated human tumors via down regulation of its target gene, 8/April/2015, 11.59 am
April 8, 2015
Adding more years into your life with microRNAs: MiRNA-27a decreases aging-related decline in muscle function and enhances the longevity of mammals via down regulation myostatin, 8/April/2015, 21.58
April 8, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Natural product-based Lifespan extension therapy: Cilostazol may prolong mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 8/April/2014, 12.07 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: It has been shown earlier that angiotensin II type I receptor (AT1R) antagonist prolongs mammalian life span. This study suggests, for the first time, that Cilostazol, by increasing the expression of their target gene,  they may suppress the expression of AT1R. And thereby, they may (1) decrease blood pressure; and (2) and extend the lifespan of an individual. Thus, pharmacological formulations encompassing “Cilostazol or its analogues” may be used to extend the life-span of an individual.

Undisclosed information: How Cilostazol suppresses the expression of  angiotensin II type I receptor (AT1R)

Comments are closed.